March 16, 2016: Here are four stocks trading with heavy volume among 53 equities making new 52-week lows in Wednesday’s session.
Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped another 6.9% on Wednesday to post a new 52-week low at $31.20 after closing at $33.51 on Tuesday. The stock’s 52-week high is $263.81. Share volume of about 50 million was more than 4 times the daily average of around 11 million shares traded. The drug company continues its slide following all the bad news on Tuesday.
Mallinckrodt PLC (NYSE: MNK) dropped about 14.5% on Wednesday to post a new 52-week low of $50.90 against a 52-week high of $134.26. The stock closed at $59.51 on Tuesday night. Volume rose to more than 7 times the stock’s daily average volume of around 2.1 million. Another drug maker’s stock that is being attacked by a short seller at a time when the sector’s stock are quite vulnerable.
Endo Pharmaceutical plc (NASDAQ: ENDP) fell by about 1.6% on Wednesday to post a new 52-week low of $32.04 against a high of $96.58. The stock closed at $32.57 on Tuesday night. Volume rose to around 12.5 million shares, about 3 times the daily average of around 4.5 million shares traded. The company climbed out of its hole today and is on track to add about 4.2% by the closing bell.
Peabody Energy Corp. (NYSE: BTU) posted a new 52-week low on Wednesday. Shares traded at a low of $2.00, down about 50%, after closing at $4.01 on Tuesday. The stock’s 52-week high is $99.90. Volume totaled nearly 5 times the daily average of around 540,000 million shares. The coal miner said Wednesday that it may not be able to continue as a going concern.
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
